ICOS Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	1/9/2006 9:25:19 AM
	of 1139

ICOS downgraded to "neutral" Monday, January 09, 2006 5:47:13 AM ET Robert W. Baird NEW YORK, January 9 (newratings.com) - Analysts at Robert W Baird downgrade ICOS Corporation (ICOS.NAS) from "outperform" to "neutral." The target price has been reduced from $32 to $30. In a research note published this morning, the analysts mention that the downgrade in the rating is based primarily on valuation. Although Cialis has witnessed robust market share gains in 2005, the drug is expected to continue to witness stable sales growth going forward, the analysts say.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next